(Q74764085)
Statements
Cyclophosphamide, adriamycin, 5-fluorouracil and high-dose toremifene for patients with advanced/recurrent breast cancer. The Japan Toremifene Cooperative Study Group (English)
T Tominaga
Y Nomura
J Uchino
K Hirata
M Kimura
M Yoshida
H Aoyama
H Kinoshita
H Koyama
Y Monden
S Takashima